bpc 157 + tb 500 BPC-157 / TB-500 Blend (Dual Peptide) BPC-157 + TB-500 Blend Peptide
Description
However, stacking an aggressive compound with known kidney toxicity with additional peptides that also need to be cleared by the kidneys would logically increase renal burden

The FDA warns that both CJC-1295 and ipamorelin are risky for immunogenicity, potentially causing life-threatening outcomes such as anaphylaxis.25 26 Cardiovascular concerns: Specifically concerning CJC-1295, the FDA warns of the risk of increased heart rate and systemic vasodilatory reaction, including flushing, warmth, and transient hypotension.25 27 Cancer: With their ability to increase the rate of cellular replication, growth hormone secretagogues in general are unsafe for cancer survivors and people with an active cancer diagnosis.28 Secretagogue use may elevate their risk for recurrence or worsen their prognosis

Side Effects Electrolyte Imbalances: Hypokalemia ( K) Hyponatremia ( Na) Hypocalcemia ( Ca) Hypomagnesemia ( Mg) Metabolic alkalosis Other Adverse Effects: Hypotension Dehydration Ototoxicity (hearing loss or tinnitus) Hyperuricemia gout Nephrotoxicity Photosensitivity 7

Bacteriostatic water 10 ml Sterile solvent for reconstitution of research peptides
